T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 404 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04390737	Evaluate the Safety and Clinical Activity of HH2853	recruiting	Phase 1 / Phase 2	254	Haihe Biopharma Co., Ltd.INDUSTRY	2	Jan 30, 2026	clinicaltrials
NCT04681105	Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies	completed	Phase 1	13	City of Hope Medical CenterOTHER	1	Jan 28, 2026	clinicaltrials